Data processing and refinement statistics. by Aleksi Sutinen (10039145)

Subjects:

Structural bioinformatics analysis of the crystallised CMT variants. by Aleksi Sutinen (10039145)

Subjects:

KL divergence. by Aleksi Sutinen (10039145)

Subjects:

Phylogenetic analyses. by Aleksi Sutinen (10039145)

Subjects:

Entropy analysis of the GDAP1 subfamily. by Aleksi Sutinen (10039145)

Subjects:

Sequence entropy analysis. by Aleksi Sutinen (10039145)

Subjects:

Entropy analysis for the large data set including the GST dataset. by Aleksi Sutinen (10039145)

Subjects:

SAXS analysis. by Aleksi Sutinen (10039145)

Subjects:

SAXS parameters. by Aleksi Sutinen (10039145)

Subjects:

Location of Arg310 outside the GST-like core. by Aleksi Sutinen (10039145)

Subjects:

GO function annotations of target genes of DEMs in soybean genotypes of (A) CK1_vs_T1 and (B) CK4_vs_T4. by Qiang Li (8118)

Concentration quotient at the electrode surfaces as a function of time after switching off the mechanical stirring of solutions, for the initial concentration quotients on the memb... by Sławomir Grzegorczyn (12035398)

IFNγ enhances the Ser/5-HT-promoted <i>Trypanosoma cruzi</i> uptake by the human U-87 MG astroglioma cells. by Glaucia Vilar-Pereira (686134)

Fx treatment abrogates the Ser/5-HT-promoted <i>Trypanosoma cruzi</i> infection of human U-87 MG astroglioma cells. by Glaucia Vilar-Pereira (686134)

Genomic sequences of SARS-CoV-2 infections and associated viral copies from cross-sectional samples collected in Connecticut, US. by Ke Li (106849)

DDX5 and DDX17 depletion does not affect doxycycline-dependent gene expression or cell viability in KSHV or EBV-infected cell lines. by Praneet Kaur Sandhu (21156149)

The numerical solution of model (1) for infected compartment vs. time with different scenarios of Phase 6 in the First Case: 1^<i>st</i> scenario, no lockdown is implemen... by Sara K. Al-Harbi (12418482)

“…<p>The numerical solution of model <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0265779#pone.0265779.e002" target="_blank">(1)</a> for infected compartment vs. time with different scenarios of Phase 6 in the First Case: 1^<i>st</i> scenario, no lockdown is implemented; 2^<i>nd</i> scenario, no lockdown while <i>SD</i> increases; 3^<i>rd</i> scenario, lockdown increases; 4^<i>th</i> scenario, <i>SD</i> increases; 5^<i>th</i> scenario, lockdown decreases; 6^<i>th</i> scenario, <i>SD</i> decreases; 7^<i>th</i> scenario, lockdown and <i>SD</i> increases; 8^<i>th</i> scenario, lockdown decreases and <i>SD</i> increases; 9^<i>th</i> scenario, <i>ρ</i> is the same as in Phase 5; 10^<i>th</i> scenario, <i>ρ</i> is the same as in Phase 5 while <i>SD</i> increases.…”

Physiological regions considering ventricular depth variations. by Inmaculada Villanueva-Baxarias (21454246)

Determination of IC₅₀ and maximum induction of VPA using Vero cells. by Amanda Watson (4447267)

Supplementary Material for: Severe Pulmonary Hypertension Associated with COPD: Hemodynamic Improvement with Specific Therapy by Girard A. (4154179)

“…First-line treatments were endothelin receptor antagonists in 11 patients, phosphodiesterase-5 inhibitors in 11 patients, calcium blocker in 1 patient, combination therapy in 3 patients including 2 with a prostanoid. …”